How Zambia fell out of favour with the US amid

Zambia's relationship with the United States has cooled significantly as tensions over a proposed minerals-for-health exchange program expose deeper rifts in bilateral trade negotiations. The initiative, designed to swap Zambian copper and cobalt for American pharmaceutical and medical technology investments, has stalled amid disagreements over pricing, governance, and strategic control—signaling a broader shift in how African nations are reassessing Western partnerships.

## Why is Zambia losing favor with Washington?

The deterioration stems from Zambia's assertion that its mineral wealth warrants stronger negotiating leverage in healthcare partnerships. Lusaka proposed that copper and cobalt exports—critical to US clean energy and defense supply chains—be directly linked to American medical device manufacturing and generic drug production facilities on African soil. The US Treasury and State Department viewed this as overreach, citing concerns that such arrangements could circumvent World Bank-approved procurement standards and create currency-hedging risks for Zambian debt obligations.

Zambia's debt restructuring (concluded in 2023 after defaulting in 2020) already constrains fiscal flexibility. Any agreement requiring commodity collateral would theoretically improve Lusaka's creditworthiness but signal to creditors that mineral revenues are being mortgaged for immediate healthcare gains—a perception that could weaken the kwacha further and raise borrowing costs.

## What are the market implications for investors?

Copper prices on the London Metal Exchange remain volatile, fluctuating between $9,200–$10,100/tonne year-to-date. Zambia, Africa's second-largest copper producer after the Democratic Republic of Congo, exports roughly 700,000 tonnes annually. A failed US deal doesn't collapse Zambia's commodity sector—China and India remain voracious buyers—but it forecloses a premium-pricing pathway that Lusaka had banked on for fiscal consolidation.

The political signal matters more than the transaction itself. By publicly challenging US terms, Zambia is repositioning toward Beijing and Moscow, both of which have shown willingness to accept resource-backed lending without the governance strings attached by the IMF or World Bank. This geopolitical realignment has already triggered a 2.3% depreciation of the kwacha against the dollar since negotiations stalled in Q3 2024.

For equity investors holding stakes in Zambian mining or healthcare firms, the impasse creates near-term uncertainty. Listed companies like Konkola Copper Mines and Nchanga Copper Mine face potential supply-chain delays if US sanctions or trade restrictions emerge. However, Zambia's mining sector remains profitable at current copper prices, and alternative buyers (particularly in Asia) ensure demand stability.

## How might this reshape Africa-US trade strategy?

The Zambia dispute signals that Washington's approach to African resource partnerships may need recalibration. Younger African governments, emboldened by debt-relief victories and Chinese capital flows, are increasingly unwilling to accept asymmetrical trade terms. Zambia's stance—linking minerals to healthcare infrastructure—is economically rational but politically challenging for US policymakers reluctant to legitimize commodities-backed development financing outside the Bretton Woods framework.

Expect the Biden and incoming Trump administrations to pivot toward bilateral investment frameworks that emphasize joint ventures and labor standards rather than direct resource-for-infrastructure swaps. Until such clarity emerges, Zambia remains in a holding pattern: mineral revenues flow steadily, but without the premium valuations that health-tech co-investment promised.

---

#